Title: Gamma-secretases: from cell biology to therapeutic strategies
Authors: Bergmans, Bruno ×
De Strooper, Bart #
Issue Date: 9-Feb-2010
Publisher: Lancet Pub. Group
Series Title: The Lancet Neurology issue:9 pages:215-226
Abstract: Presenilins form the catalytic part of the gamma-secretases, protein complexes that are responsible for the intramembranous cleavage of transmembrane proteins. The presenilins are involved in several biological functions, but are best known for their role in the generation of the beta-amyloid (A beta) peptide in Alzheimer's disease and are therefore thought to be important drug targets for this disorder. Mutations in the presenilin genes cause early-onset familial Alzheimer's disease, but mutation carriers have substantial phenotypic heterogeneity. Recent evidence implicating presenilin mutations in non-Alzheimer's dementias, including frontotemporal dementia and Lewy body dementia, warrants further investigation. An increased understanding of the diversity of the molecular cell biology of the gamma-secretase complex and the effects of clinical mutations in the presenilin genes might help pave the way for improved development of drugs that are designed to target gamma-secretase enzymatic activity in Alzheimer's disease and potentially in other neurological diseases.
ISSN: 1474-4422
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Department of Human Genetics - miscellaneous
Laboratory for the Research of Neurodegenerative Diseases
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
BergmansDeStrooper_LancetNeurology.pdf Published 569KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science